Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-026993
Filing Date
2019-11-08
Accepted
2019-11-08 17:07:36
Documents
2
Period of Report
2019-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1599
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3901
  Complete submission text file 0000899243-19-026993.txt   7025
Mailing Address C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR CAMBRIDGE MA 02139
Business Address
DiPalma Stephen J. (Reporting) CIK: 0001426479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38266 | Film No.: 191204880

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations